Literature DB >> 16411526

Take care in how you store your PD fluids: actual temperature determines the balance between reactive and non-reactive GDPs.

Martin Erixon1, Anders Wieslander, Torbjörn Lindén, Ola Carlsson, Gunita Forsbäck, Eva Svensson, Jan Ake Jönsson, Per Kjellstrand.   

Abstract

OBJECTIVE: During heat sterilization and during prolonged storage, glucose in peritoneal dialysis fluids (PDF) degrades to carbonyl compounds commonly known as glucose degradation products (GDPs). Of these, 3,4-dideoxyglucosone-3-ene (3,4-DGE) is the most cytotoxic. It is an intermediate in degradation between 3-deoxyglucosone (3-DG) and 5-hydroxymethyl-2-furaldehyde (5-HMF). We have earlier reported that there seems to be equilibrium between these GDPs in PDF. The aim of the present study was to investigate details of this equilibrium.
METHODS: Aqueous solutions of pure 3-DG, 3,4-DGE, and 5-HMF were incubated at 40 degrees C for 40 days. Conventional and low-GDP fluids were incubated at various temperatures for up to 3 weeks. Formaldehyde, acetaldehyde, glyoxal, methylglyoxal, 3-DG, 3,4-DGE, and 5-HMF were analyzed using high performance liquid chromatography.
RESULTS: Incubation of 100 micromol/L 3,4-DGE resulted in the production of 36 micromol/L 3-DG, 4 micromol/L 5-HMF, and 40 micromol/L unidentified substances. With the same incubation, 200 micromol/L 3-DG was converted to 9 micromol/L 3,4-DGE, 6 micromol/L 5-HMF, and 14 micromol/L unidentified substances. By contrast, 100 micromol/L 5-HMF was uninfLuenced byincubation. In a conventional PDF incubated at 60 degrees C for 1 day, the 3,4-DGE concentration increased from 14 to a maximum of 49 micromol/L. When the fluids were returned to room temperature, the concentration decreased but did not reach original values until after 40 days. In a low GDP fluid, 3,4-DGE increased and decreased in the same manner as in the conventional fluid but reached a maximum of only 0.8 micromol/L.
CONCLUSIONS: Considerable amounts of 3,4-DGE may be recruited by increases in temperature in conventional PDFs. Lowering the temperature will again reduce the concentration but much more time will be needed. Precursors for 3,4-DGE recruitment are most probably 3-DG and the enol 3-deoxyaldose-2-ene, but not 5-HMF. Considering the ease at which 3,4-DGE is recruited from its pool of precursors and the difficulty of getting rid of it again, one should be extremely careful with the temperatures conventional PDFs are exposed to.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16411526

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  5 in total

1.  Impact of 3,4-dideoxyglucosone-3-ene (3,4-DGE) on cytotoxicity of acidic heat-sterilized peritoneal dialysis fluid.

Authors:  Tadashi Tomo; Eiji Okabe; Takashi Yamamoto; Shinji Namoto; Tomohiko Iwashita; Kazuhiro Matsuyama; Jun-ichi Kadota
Journal:  J Artif Organs       Date:  2007-03-23       Impact factor: 1.731

2.  Infusion fluids contain harmful glucose degradation products.

Authors:  Anna Bryland; Marcus Broman; Martin Erixon; Bengt Klarin; Torbjörn Lindén; Hans Friberg; Anders Wieslander; Per Kjellstrand; Claudio Ronco; Ola Carlsson; Gabriela Godaly
Journal:  Intensive Care Med       Date:  2010-04-16       Impact factor: 17.440

3.  Citrate treatment reduces endothelial death and inflammation under hyperglycaemic conditions.

Authors:  Anna Bryland; Anders Wieslander; Ola Carlsson; Thomas Hellmark; Gabriela Godaly
Journal:  Diab Vasc Dis Res       Date:  2011-11-01       Impact factor: 3.291

4.  Cytotoxic glucose degradation products in fluids for peritoneal dialysis.

Authors:  Noushin Adib; Maryam Shekarchi; Homa Hajimehdipoor; Gloria Shalviri; Maral Shekarchi; Maryam Imaninejad
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

5.  Degradation and de novo formation of nine major glucose degradation products during storage of peritoneal dialysis fluids.

Authors:  Sabrina Gensberger-Reigl; Ingrid Weigel; Joachim Stützer; Andrea Auditore; Tim Nikolaus; Monika Pischetsrieder
Journal:  Sci Rep       Date:  2022-03-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.